User manual
ioAstrocytes
cat no ioEA1093 | Human iPSC-derived astrocytes
View MEA-compatible ioAstrocytes 2.0
cat no ioEA1093 | Human iPSC-derived astrocytes
ioAstrocytes are delivered in a cryopreserved format. The user manual for the generation of the cells follows a simple three-phase process.
- Induction
Human iPSCs are exposed to an induction protocol. This leads to irreversible loss of pluripotency, and the synchronised homogeneous production of ioAstrocytes. The ioAstrocytes are subsequently cryopreserved for distribution. - Phase 1 鈥� Stabilisation (day 0 to day 2)
The ioAstrocytes are revived at the user鈥檚 laboratory using the recommended medium. After 24h a full media change. - Phase 2 鈥� Pre-maintenance (day 2 to day 8)
Every 48h a 50% media change is performed with the recommended medium. - Phase 3 鈥� Maintenance (day 8 onwards):
The ioAstrocytes require full media change switching to recommended medium. Half media changes are subsequently performed every 48h onwards.
91探花